Skip to content

13F-HR filed by BRAIDWELL LP

BRAIDWELL LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 72 holding rows worth $2,722,670,757.

Accession
0001420506-24-000478
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 72 entries on the cover page, a total value of $2,722,670,757 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,722,670,757 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC40131MAB5NOTE 11/1268,252,000$189,117,660dollars as filedprincipal
BRIDGEBIO PHARMA INC10806XAB8NOTE 2.500% 3/1114,338,000$138,406,149dollars as filedprincipal
Ascendis Pharma A/S04351PAD3Convertible bond126,897,000$130,386,668dollars as filedprincipal
EXACT SCIENCES CORP30063PAC9NOTE 0.375% 3/0131,000,000$123,140,000dollars as filedprincipal
NOVOCURE LTD67011XAB9NOTE 11/0135,834,000$117,917,495dollars as filedprincipal
NEUROCRINE BIOSCIENCES INC64125C109COM715,209$94,235,938dollars as filed
VAXCYTE INC COM92243G108Stock1,289,965$81,009,802dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock1,647,311$75,875,145dollars as filed
NUVASIVE INC670704AJ4NOTE 0.375% 3/180,530,000$74,288,925dollars as filedprincipal
INSULET CORP45784PAK7NOTE 0.375% 9/063,000,000$72,702,000dollars as filedprincipal
TANDEM DIABETES CARE INC875372AB0NOTE 1.500% 5/071,051,000$67,178,721dollars as filedprincipal
Day One Biopharmaceuticals Inc23954D109Common Stock4,215,573$61,547,366dollars as filed
IRHYTHM HOLDINGS INC COM450056106Stock568,157$60,815,525dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR153,204$58,283,398dollars as filed
Bridgebio Pharma Inc Note 2.250 percent 2/010806XAD4Convertible67,294,000$57,327,759dollars as filedprincipal
INSMED INC457669AA7NOTE 1.750% 1/152,388,000$56,123,264dollars as filedprincipal
PENUMBRA INC COM70975L107Stock222,792$56,041,100dollars as filed
SAREPTA THERAPEUTICS INC803607AD2NOTE 1.250% 9/150,666,000$51,522,255dollars as filedprincipal
NEOGENOMICS INC64049MAB6NOTE 0.250% 1/165,601,000$50,199,537dollars as filedprincipal
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/156,031,000$47,699,190dollars as filedprincipal
DEXCOM INC252131AK3NOTE 0.250%11/145,000,000$47,205,000dollars as filedprincipal
KEROS THERAPEUTICS INC COM492327101Stock1,118,961$44,489,889dollars as filed
PARAGON 28 INC69913P105COM3,361,824$41,787,472dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR611,365$41,768,457dollars as filed
Thermo Fisher Scientific Inc.883556102COM75,749$40,206,812dollars as filed
ALIGN TECHNOLOGY INC COM016255101Stock146,313$40,089,762dollars as filed
IRONWOOD PHARMACEUTICALS INC46333XAF5BOND37,509,000$39,478,223dollars as filedprincipal
NEVRO CORP64157F103COM1,776,368$38,227,439dollars as filed
INSPIRE MED SYS INC COM457730109Stock184,658$37,564,977dollars as filed
ORTHOPEDIATRICS CORP68752L100COMMON STOCK1,107,770$36,013,603dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock5,718,477$34,253,677dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS562,600$33,851,642dollars as filed
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK5,040,635$33,016,159dollars as filed
KARYOPHARM THERAPEUTICS INC48576UAA4BOND65,976,000$32,987,982dollars as filedprincipal
LANTHEUS HLDGS INC516544103COM495,100$30,696,200dollars as filed
ALPHATEC HLDGS INC02081GAB8NOTE 0.750% 8/026,750,000$28,368,375dollars as filedprincipal
ALECTOR INC014442107COMMON STOCK3,324,308$26,527,978dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock196,200$24,340,572dollars as filed
Tourmaline Bio Inc89157D105Common Stock906,820$23,740,548dollars as filed
GUARDANT HEALTH INC COM40131M109Stock758,928$20,529,002dollars as filed
GLAUKOS CORP COM377322102Stock242,760$19,296,992dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock681,101$19,029,962dollars as filed
DECIPHERA PHARMACEUTICALS IN24344T101COM1,169,490$18,863,874dollars as filed
REPLIGEN CORP COM759916109Stock102,698$18,465,100dollars as filed
MINERALYS THERAPEUTICS INC603170101COM2,023,900$17,405,540dollars as filed
IRONWOOD PHARMACEUTICALS INC46333XAH1NOTE 1.500% 6/115,500,000$16,871,750dollars as filedprincipal
HARROW INC415858109COM1,498,584$16,784,141dollars as filed
Amgen Inc.031162100COM58,200$16,762,764dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock2,318,050$15,044,145dollars as filed
INVITAE CORP46185LAB9NOTE 2.000% 9/016,781,000$14,850,554dollars as filedprincipal
THIRD HARMONIC BIO INC88427A107COM1,316,018$14,436,717dollars as filed
OUTSET MEDICAL INC690145107COM2,400,427$12,986,310dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,240,865$12,644,414dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY280,158$11,419,240dollars as filed
TRAVERE THERAPEUTICS INC89422GAA5CNV16,850,000$11,121,000dollars as filedprincipal
SPYRE THERAPEUTICS INC00773J202COM NEW515,000$11,082,800dollars as filed
MERUS N VN5749R100COM370,679$10,193,673dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock755,811$10,052,286dollars as filed
PULMONX CORP745848101COM787,954$10,046,414dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock461,769$9,909,563dollars as filed
RAPT THERAPEUTICS INC75382E109COM389,300$9,674,105dollars as filed
NEOGENOMICS INC64049MAA8Convertible Debt10,000,000$9,375,000dollars as filedprincipal
TRANSMEDICS GROUP INC89377M109COM117,701$9,290,140dollars as filed
CUTERA INC232109AD0NOTE 2.250% 6/031,900,000$8,373,750dollars as filedprincipal
DBV TECHNOLOGIES S A23306J101ADR7,843,285$7,473,082dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM323,102$7,037,162dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock1,357,490$6,651,701dollars as filed
CUTERA INC232109AG3NOTE 4.000% 6/029,000,000$6,543,125dollars as filedprincipal
IONIS PHARMACEUTICALS INC462222AD2NOTE 4/05,240,000$5,538,680dollars as filedprincipal
HILLEVAX INC43157M102COM203,407$3,264,682dollars as filed
NANOSTRING TECHNOLOGIES INC63009RAD1BOND3,650,000$2,724,718dollars as filedprincipal
COMPASS THERAPEUTICS INC20454B104COM317,761$495,707dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-24-000478this filing2024-02-14acceptance time not in the bulk data set